How Conte was paid
$705,675 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Other | Total |
|---|---|---|---|---|---|
| Lisa A. ContePresident & Chief Executive Officer | $600,005 | $41,171 | $38,713 | $25,786 | $705,675 |
| Pravin Chaturvedi, Ph.D.Chief Scientific Officer | $484,585 | $16,906 | $15,896 | $52,400 | $569,787 |
| Steven R. King, Ph.D.Chief, Sustainable Supply, Ethnobotanical Research & Intellectual Property | $367,369 | $16,906 | $15,896 | $49,306 | $449,476 |
| Jonathan WolinChief of Staff, General Counsel & Chief Compliance Officer | $412,777 | $16,906 | $15,896 | $60,947 | $506,525 |
What changed and why
- $706KCEO total compensation decreased to $705,675 in 2025 from $875,320 in 2024.
- There were no annual base salary increases for named executive officers in 2025.
- All stock options and RSUs issued to named executive officers vest upon a change in control.
Other Jaguar Health proxy statements
- 2025 proxy statement
Lisa A. Conte paid $875,320 (+7% on the year).
Filed Jul 21, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.